II
iBio, Inc. Common Stock
🇺🇸XNYS.IBIOUnited StatesHealthcare
$1.84USDdown -0.06 (-3.16%)OpenEnd of day6:55 PM
Price$1.84-0.06 (-3.16%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US4510332038
- CUSIP
- 451033203
Company
- Employees
- 23
- Headquarters
- San Diego, United States
- Website
- https://ibioinc.com
- CEO
- Dr. Martin B. Brenner D.V.M., Ph.D.
Market
- Shares outstanding
- 22.5M
- Market cap
- $41.38M
Highlights
- Market cap
- $41.38M
- EPS LTM
- -$0.32
- P/E LTM
- -5.79calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $100K-75%down year on year
- Net income
- -$33.04M-79.81%down year on year
- Gross margin
- 100%
- Free cash flow
- -$23.8M-55.33%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.